U.S. Markets closed

Tonix Pharmaceuticals Holding Corp. (TNXP)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
4.46+0.11 (+2.53%)
At close: 4:00PM EDT
People also watch
CERUCBIOHTBXMRNSIMNP

Tonix Pharmaceuticals Holding Corp.

509 Madison Avenue
Suite 306
New York, NY 10022
United States
212-980-9155
http://www.tonixpharma.com

SectorHealthcare
IndustryDrug Manufacturers - Major
Full Time Employees18

Key Executives

NameTitlePayExercisedAge
Dr. Seth Lederman M.D.Co-Founder, Chairman, Chief Exec. Officer, Pres472.5kN/A59
Dr. Donald W. Landry M.D., Ph.D.Co-Founder and Director45.75kN/A62
Mr. Bradley Saenger CPAChief Financial Officer and Treasurer301.36kN/A43
Dr. Gregory M. Sullivan M.D.Chief Medical Officer and Sec.335kN/A51
Mrs. Jessica Edgar MorrisExec. VP of OperationsN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Tonix Pharmaceuticals Holding Corp., a clinical-stage pharmaceutical company, develops medicines for common disorders of the central nervous system. The company’s lead program focuses on post-traumatic stress disorder (PTSD) that is characterized by chronic disability, inadequate treatment options, high utilization of healthcare services, and economic burden. Its lead product candidate includes TNX-102 SL, a cyclobenzaprine HCl sublingual tablet, a Phase III clinical stage for the treatment of PTSD; and Phase II clinical stage for the treatment of military-related PTSD. The company also develops TNX-301, a fixed dose combination drug product that contains disulfiram and selegiline for the treatment of alcohol use disorders, as well as biodefense development programs for protection from smallpox virus and radiation injury. Tonix Pharmaceuticals Holding Corp. was founded in 2007 and is based in New York, New York.

Corporate Governance

Tonix Pharmaceuticals Holding Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.